134 related articles for article (PubMed ID: 12121279)
1. CD80 (B7-1) and CD86 (B7-2) genes and genetic susceptibility to coeliac disease.
Woolley N; Holopainen P; Bourgain C; Mustalahti K; Collin P; Mäki M; Partanen J
Eur J Immunogenet; 2002 Aug; 29(4):331-3. PubMed ID: 12121279
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells.
Luque I; Reyburn H; Strominger JL
Hum Immunol; 2000 Aug; 61(8):721-8. PubMed ID: 10980383
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell response to L14 pig cell line transfected with human ligands CD80 and CD86.
Millán O; Rojo I; Juan M; Vilardell C; Yagüe J; Vives J; Martorell J
Transplant Proc; 1999 Sep; 31(6):2630. PubMed ID: 10500750
[No Abstract] [Full Text] [Related]
5. Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.
Pettit SJ; Ali S; O'Flaherty E; Griffiths TR; Neal DE; Kirby JA
Clin Exp Immunol; 1999 Apr; 116(1):48-56. PubMed ID: 10209504
[TBL] [Abstract][Full Text] [Related]
6. Characterization of rat CD80 and CD86 by molecular cloning and mAb.
Maeda K; Sato T; Azuma M; Yagita H; Okumura K
Int Immunol; 1997 Jul; 9(7):993-1000. PubMed ID: 9237108
[TBL] [Abstract][Full Text] [Related]
7. Novel transcripts encoding secreted forms of feline CD80 and CD86 costimulatory molecules.
Yang S; Sellins KS; Powell T; Stoneman E; Sim GK
Vet Immunol Immunopathol; 2001 Aug; 81(1-2):15-21. PubMed ID: 11498243
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of the costimulatory molecules B7-1 (CD80) and B7-2 (CD86) in an in vitro model of the human blood--brain barrier.
Omari KI; Dorovini-Zis K
J Neuroimmunol; 2001 Feb; 113(1):129-141. PubMed ID: 11137584
[TBL] [Abstract][Full Text] [Related]
9. The costimulatory genes Cd80 and Cd86 are linked on mouse chromosome 16 and human chromosome 3.
Reeves RH; Patch D; Sharpe AH; Borriello F; Freeman GJ; Edelhoff S; Disteche C
Mamm Genome; 1997 Aug; 8(8):581-2. PubMed ID: 9250865
[No Abstract] [Full Text] [Related]
10. B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-beta mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
Monteyne P; Guillaume B; Sindic CJ
J Neuroimmunol; 1998 Nov; 91(1-2):198-203. PubMed ID: 9846836
[TBL] [Abstract][Full Text] [Related]
11. Sequence analyses of feline B7 costimulatory molecules.
Choi IS; Hash SM; Winslow BJ; Collisson EW
Vet Immunol Immunopathol; 2000 Mar; 73(3-4):219-31. PubMed ID: 10713336
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy.
Santos DO; Santos SL; Esquenazi D; Nery JA; Defruyt M; Lorré K; Van Heuverswyn H
Nihon Hansenbyo Gakkai Zasshi; 2001 Feb; 70(1):15-24. PubMed ID: 11244783
[TBL] [Abstract][Full Text] [Related]
13. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
14. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
15. New forms of dog CD80 and CD86 transcripts that encode secreted B7 molecules.
Yang S; Sim GK
Immunogenetics; 1999 Dec; 50(5-6):349-53. PubMed ID: 10630300
[No Abstract] [Full Text] [Related]
16. Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig.
Nishimura Y; Shimojima M; Miyazawa T; Sato E; Nakamura K; Izumiya Y; Ikeda Y; Mikami T; Takahashi E
Eur J Immunogenet; 2000; 27(5-6):427-30. PubMed ID: 11029611
[TBL] [Abstract][Full Text] [Related]
17. Regulation of self-tolerance by CD80/CD86 interactions.
Lu P; Wang YL; Linsley PS
Curr Opin Immunol; 1997 Dec; 9(6):858-62. PubMed ID: 9492990
[TBL] [Abstract][Full Text] [Related]
18. CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.
Gaspari AA; Burns R; Nasir A; Ramirez D; Barth RK; Haidaris CG
Infect Immun; 1998 Sep; 66(9):4440-9. PubMed ID: 9712799
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 inhibits the immune stimulatory potential of melanoma cells retrovirally transduced with human B7.1 or B7.2.
Geertsen R; Yue FY; Pavlovic J; Laine E; Dummer R
Adv Exp Med Biol; 1998; 451():179-88. PubMed ID: 10026870
[No Abstract] [Full Text] [Related]
[Next] [New Search]